Metabolic reprogramming of tumor cells involves upregulation of fatty acid (FA) synthesis to support high bioenergetic demands and membrane synthesis. This has been shown for cytosolic synthesis of FAs with up to 16 carbon atoms. Synthesis of long-chain fatty acids (LCFAs), including ω-6 and ω-3 polyunsaturated FAs, takes place at the endoplasmic reticulum. Despite increasing evidence for an important role of LCFAs in cancer, the impact of their synthesis in cancer cell growth has scarcely been studied. Here, we demonstrated that silencing of 17β-hydroxysteroid dehydrogenase type 12 (17β-HSD12), essentially catalyzing the 3-ketoacyl-CoA reduction step in LCFA production, modulates proliferation and migration of breast cancer cells in a cell line-dependent manner. Increased proliferation and migration after 17β-HSD12 knockdown were partly mediated by metabolism of arachidonic acid towards COX2 and CYP1B1-derived eicosanoids. Decreased proliferation was rescued by increased glucose concentration and was preceded by reduced ATP production through oxidative phosphorylation and spare respiratory capacity. In addition, 17β-HSD12 silencing was accompanied by alterations in unfolded protein response, including a decrease in CHOP expression and increase in eIF2α activation and the folding chaperone ERp44. Our study highlights the significance of LCFA biosynthesis for tumor cell physiology and unveils unknown aspects of breast cancer cell heterogeneity.

Department of Biochemical Sciences Faculty of Pharmacy in Hradec Králové Charles University Heyrovskeho 1203 500 05 Hradec Kralove Czech Republic

Division of Molecular and Systems Toxicology Department of Pharmaceutical Sciences University of Basel Klingelbergstrasse 50 4056 Basel Switzerland

Zobrazit více v PubMed

Wakil SJ. Fatty acid synthase, a proficient multifunctional enzyme. Biochemistry. 1989;28(11):4523–4530. doi: 10.1021/bi00437a001. PubMed DOI

Kihara A. Very long-chain fatty acids: elongation, physiology and related disorders. J Biochem. 2012;152(5):387–395. doi: 10.1093/jb/mvs105. PubMed DOI

Medes G, Thomas A, Weinhouse S. Metabolism of neoplastic tissue. IV. A study of lipid synthesis in neoplastic tissue slices in vitro. Cancer Res. 1953;13(1):27–29. PubMed

Baenke F, Peck B, Miess H, Schulze A. Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development. Dis Model Mech. 2013;6(6):1353–1363. doi: 10.1242/dmm.011338. PubMed DOI PMC

Rohrig F, Schulze A. The multifaceted roles of fatty acid synthesis in cancer. Nat Rev Cancer. 2016;16(11):732–749. doi: 10.1038/nrc.2016.89. PubMed DOI

Beloribi-Djefaflia S, Vasseur S, Guillaumond F. Lipid metabolic reprogramming in cancer cells. Oncogenesis. 2016;5:e189. doi: 10.1038/oncsis.2015.49. PubMed DOI PMC

Kuhajda FP, Jenner K, Wood FD, Hennigar RA, Jacobs LB, Dick JD, Pasternack GR. Fatty acid synthesis: a potential selective target for antineoplastic therapy. Proc Natl Acad Sci USA. 1994;91(14):6379–6383. doi: 10.1073/pnas.91.14.6379. PubMed DOI PMC

Angeles TS, Hudkins RL. Recent advances in targeting the fatty acid biosynthetic pathway using fatty acid synthase inhibitors. Expert Opin Drug Discov. 2016;11(12):1187–1199. doi: 10.1080/17460441.2016.1245286. PubMed DOI

Menendez JA, Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer. 2007;7(10):763–777. doi: 10.1038/nrc2222. PubMed DOI

Saini RK, Keum YS. Omega-3 and omega-6 polyunsaturated fatty acids: dietary sources, metabolism, and significance—a review. Life Sci. 2018;203:255–267. doi: 10.1016/j.lfs.2018.04.049. PubMed DOI

Wang D, Dubois RN. Eicosanoids and cancer. Nat Rev Cancer. 2010;10(3):181–193. doi: 10.1038/nrc2809. PubMed DOI PMC

Hu J, Fromel T, Fleming I. Angiogenesis and vascular stability in eicosanoids and cancer. Cancer Metastasis Rev. 2018 doi: 10.1007/s10555-018-9732-2. PubMed DOI

Fabian CJ, Kimler BF, Hursting SD. Omega-3 fatty acids for breast cancer prevention and survivorship. Breast Cancer Res. 2015;17:62. doi: 10.1186/s13058-015-0571-6. PubMed DOI PMC

Azordegan N, Fraser V, Le K, Hillyer LM, Ma DW, Fischer G, Moghadasian MH. Carcinogenesis alters fatty acid profile in breast tissue. Mol Cell Biochem. 2013;374(1–2):223–232. doi: 10.1007/s11010-012-1523-4. PubMed DOI

Abel S, De Kock M, van Schalkwyk DJ, Swanevelder S, Kew MC, Gelderblom WC. Altered lipid profile, oxidative status and hepatitis B virus interactions in human hepatocellular carcinoma. Prostaglandins Leukot Essent Fatty Acids. 2009;81(5–6):391–399. doi: 10.1016/j.plefa.2009.08.003. PubMed DOI

Yang K, Li H, Dong J, Dong Y, Wang CZ. Expression profile of polyunsaturated fatty acids in colorectal cancer. World J Gastroenterol. 2015;21(8):2405–2412. doi: 10.3748/wjg.v21.i8.2405. PubMed DOI PMC

Wakai K, Tamakoshi K, Date C, Fukui M, Suzuki S, Lin Y, Niwa Y, Nishio K, Yatsuya H, Kondo T, Tokudome S, Yamamoto A, Toyoshima H, Tamakoshi A, JACC Study Group Dietary intakes of fat and fatty acids and risk of breast cancer: a prospective study in Japan. Cancer Sci. 2005;96(9):590–599. doi: 10.1111/j.1349-7006.2005.00084.x. PubMed DOI PMC

Brasky TM, Lampe JW, Potter JD, Patterson RE, White E. Specialty supplements and breast cancer risk in the VITamins And Lifestyle (VITAL) Cohort. Cancer Epidemiol Biomarkers Prev. 2010;19(7):1696–1708. doi: 10.1158/1055-9965.EPI-10-0318. PubMed DOI PMC

Black HS, Rhodes LE. Potential benefits of omega-3 fatty acids in non-melanoma skin cancer. J Clin Med. 2016;5(2):23. doi: 10.3390/jcm5020023. PubMed DOI PMC

Serini S, Ottes Vasconcelos R, Fasano E, Calviello G. How plausible is the use of dietary n-3 PUFA in the adjuvant therapy of cancer? Nutr Res Rev. 2016;29(1):102–125. doi: 10.1017/S0954422416000044. PubMed DOI

Nagasaki S, Suzuki T, Miki Y, Akahira J, Kitada K, Ishida T, Handa H, Ohuchi N, Sasano H. 17Beta-hydroxysteroid dehydrogenase type 12 in human breast carcinoma: a prognostic factor via potential regulation of fatty acid synthesis. Cancer Res. 2009;69(4):1392–1399. doi: 10.1158/0008-5472.CAN-08-0821. PubMed DOI

Szajnik M, Szczepanski MJ, Elishaev E, Visus C, Lenzner D, Zabel M, Glura M, DeLeo AB, Whiteside TL. 17beta Hydroxysteroid dehydrogenase type 12 (HSD17B12) is a marker of poor prognosis in ovarian carcinoma. Gynecol Oncol. 2012;127(3):587–594. doi: 10.1016/j.ygyno.2012.08.010. PubMed DOI PMC

Kemilainen H, Huhtinen K, Auranen A, Carpen O, Strauss L, Poutanen M. The expression of HSD17B12 is associated with COX-2 expression and is increased in high-grade epithelial ovarian cancer. Oncology. 2018;94(4):233–242. doi: 10.1159/000485624. PubMed DOI

Yang Y, Fang X, Yang R, Yu H, Jiang P, Sun B, Zhao Z. MiR-152 regulates apoptosis and triglyceride production in MECs via targeting ACAA2 and HSD17B12 genes. Sci Rep. 2018;8(1):417. doi: 10.1038/s41598-017-18804-x. PubMed DOI PMC

Uhlen M, Zhang C, Lee S, Sjostedt E, Fagerberg L, Bidkhori G, Benfeitas R, Arif M, Liu Z, Edfors F, Sanli K, von Feilitzen K, Oksvold P, Lundberg E, Hober S, Nilsson P, Mattsson J, Schwenk JM, Brunnstrom H, Glimelius B, Sjoblom T, Edqvist PH, Djureinovic D, Micke P, Lindskog C, Mardinoglu A, Ponten F. A pathology atlas of the human cancer transcriptome. Science. 2017 doi: 10.1126/science.aan2507. PubMed DOI

Tsachaki M, Mladenovic N, Stambergova H, Birk J, Odermatt A. Hexose-6-phosphate dehydrogenase controls cancer cell proliferation and migration through pleiotropic effects on the unfolded-protein response, calcium homeostasis, and redox balance. FASEB J. 2018;32(5):2690–2705. doi: 10.1096/fj.201700870RR. PubMed DOI PMC

Engeli RT, Rhouma BB, Sager CP, Tsachaki M, Birk J, Fakhfakh F, Keskes L, Belguith N, Odermatt A. Biochemical analyses and molecular modeling explain the functional loss of 17beta-hydroxysteroid dehydrogenase 3 mutant G133R in three Tunisian patients with 46, XY Disorders of Sex Development. J Steroid Biochem Mol Biol. 2016;155(Pt A):147–154. doi: 10.1016/j.jsbmb.2015.10.023. PubMed DOI

Baker-LePain JC, Sarzotti M, Fields TA, Li CY, Nicchitta CV. GRP94 (gp96) and GRP94 N-terminal geldanamycin binding domain elicit tissue nonrestricted tumor suppression. J Exp Med. 2002;196(11):1447–1459. doi: 10.1084/jem.20020436. PubMed DOI PMC

Flanagan L, Van Weelden K, Ammerman C, Ethier SP, Welsh J. SUM-159PT cells: a novel estrogen independent human breast cancer model system. Breast Cancer Res Treat. 1999;58(3):193–204. doi: 10.1023/A:1006331716981. PubMed DOI

Reddy JK, Hashimoto T. Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system. Annu Rev Nutr. 2001;21:193–230. doi: 10.1146/annurev.nutr.21.1.193. PubMed DOI

Van den Branden C, Roels F. Thioridazine: a selective inhibitor of peroxisomal beta-oxidation in vivo. FEBS Lett. 1985;187(2):331–333. doi: 10.1016/0014-5793(85)81270-9. PubMed DOI

Shi R, Zhang Y, Shi Y, Shi S, Jiang L. Inhibition of peroxisomal beta-oxidation by thioridazine increases the amount of VLCFAs and Abeta generation in the rat brain. Neurosci Lett. 2012;528(1):6–10. doi: 10.1016/j.neulet.2012.08.086. PubMed DOI

Hensley CT, Wasti AT, DeBerardinis RJ. Glutamine and cancer: cell biology, physiology, and clinical opportunities. J Clin Investig. 2013;123(9):3678–3684. doi: 10.1172/JCI69600. PubMed DOI PMC

Feng YX, Sokol ES, Gupta PB. The endoplasmic reticulum may be an Achilles’ heel of cancer cells that have undergone an epithelial-to-mesenchymal transition. Mol Cell Oncol. 2014;1(2):e961822. doi: 10.4161/23723548.2014.961822. PubMed DOI PMC

Kato H, Nishitoh H. Stress responses from the endoplasmic reticulum in cancer. Front Oncol. 2015;5:93. doi: 10.3389/fonc.2015.00093. PubMed DOI PMC

Fuchs CD, Claudel T, Scharnagl H, Stojakovic T, Trauner M. FXR controls CHOP expression in steatohepatitis. FEBS Lett. 2017;591(20):3360–3368. doi: 10.1002/1873-3468.12845. PubMed DOI PMC

Currie E, Schulze A, Zechner R, Walther TC, Farese RV., Jr Cellular fatty acid metabolism and cancer. Cell Metab. 2013;18(2):153–161. doi: 10.1016/j.cmet.2013.05.017. PubMed DOI PMC

Ikeda M, Kanao Y, Yamanaka M, Sakuraba H, Mizutani Y, Igarashi Y, Kihara A. Characterization of four mammalian 3-hydroxyacyl-CoA dehydratases involved in very long-chain fatty acid synthesis. FEBS Lett. 2008;582(16):2435–2440. doi: 10.1016/j.febslet.2008.06.007. PubMed DOI

Moon YA, Horton JD. Identification of two mammalian reductases involved in the two-carbon fatty acyl elongation cascade. J Biol Chem. 2003;278(9):7335–7343. doi: 10.1074/jbc.M211684200. PubMed DOI

Gregory MK, Gibson RA, Cook-Johnson RJ, Cleland LG, James MJ. Elongase reactions as control points in long-chain polyunsaturated fatty acid synthesis. PLoS One. 2011;6(12):e29662. doi: 10.1371/journal.pone.0029662. PubMed DOI PMC

Gregory MK, Cleland LG, James MJ. Molecular basis for differential elongation of omega-3 docosapentaenoic acid by the rat Elovl5 and Elovl2. J Lipid Res. 2013;54(10):2851–2857. doi: 10.1194/jlr.M041368. PubMed DOI PMC

Robichaud PP, Munganyiki JE, Boilard E, Surette ME. Polyunsaturated fatty acid elongation and desaturation in activated human T-cells: ELOVL5 is the key elongase. J Lipid Res. 2018;59(12):2383–2396. doi: 10.1194/jlr.M090050. PubMed DOI PMC

Kabeya N, Chiba M, Haga Y, Satoh S, Yoshizaki G. Cloning and functional characterization of fads2 desaturase and elovl5 elongase from Japanese flounder Paralichthys olivaceus. Comp Biochem Physiol B: Biochem Mol Biol. 2017;214:36–46. doi: 10.1016/j.cbpb.2017.09.002. PubMed DOI

Li S, Yuan Y, Wang T, Xu W, Li M, Mai K, Ai Q. Molecular cloning, functional characterization and nutritional regulation of the putative elongase Elovl5 in the orange-spotted grouper (Epinephelus coioides) PLoS One. 2016;11(3):e0150544. doi: 10.1371/journal.pone.0150544. PubMed DOI PMC

Lin Z, Huang Y, Zou W, Rong H, Hao M, Wen X. Cloning, tissue distribution, functional characterization and nutritional regulation of a fatty acyl Elovl5 elongase in chu’s croaker Nibea coibor. Gene. 2018;659:11–21. doi: 10.1016/j.gene.2018.03.046. PubMed DOI

VanderSluis L, Mazurak VC, Damaraju S, Field CJ. Determination of the relative efficacy of eicosapentaenoic acid and docosahexaenoic acid for anti-cancer effects in human breast cancer models. Int J Mol Sci. 2017;18(12):E2607. doi: 10.3390/ijms18122607. PubMed DOI PMC

Han L, Song S, Niu Y, Meng M, Wang C. Eicosapentaenoic acid (EPA) induced macrophages activation through GPR120-mediated Raf-ERK1/2-IKKbeta-NF-kappaB p65 signaling pathways. Nutrients. 2017;9(9):E937. doi: 10.3390/nu9090937. PubMed DOI PMC

Verlengia R, Gorjao R, Kanunfre CC, Bordin S, de Lima TM, Martins EF, Newsholme P, Curi R. Effects of EPA and DHA on proliferation, cytokine production, and gene expression in Raji cells. Lipids. 2004;39(9):857–864. doi: 10.1007/s11745-004-1307-2. PubMed DOI

Covey TM, Edes K, Fitzpatrick FA. Akt activation by arachidonic acid metabolism occurs via oxidation and inactivation of PTEN tumor suppressor. Oncogene. 2007;26(39):5784–5792. doi: 10.1038/sj.onc.1210391. PubMed DOI

Hii CS, Moghadammi N, Dunbar A, Ferrante A. Activation of the phosphatidylinositol 3-kinase-Akt/protein kinase B signaling pathway in arachidonic acid-stimulated human myeloid and endothelial cells: involvement of the ErbB receptor family. J Biol Chem. 2001;276(29):27246–27255. doi: 10.1074/jbc.M103250200. PubMed DOI

Hughes-Fulford M, Li CF, Boonyaratanakornkit J, Sayyah S. Arachidonic acid activates phosphatidylinositol 3-kinase signaling and induces gene expression in prostate cancer. Cancer Res. 2006;66(3):1427–1433. doi: 10.1158/0008-5472.CAN-05-0914. PubMed DOI

Witting M, Schmitt-Kopplin P. The Caenorhabditis elegans lipidome: a primer for lipid analysis in Caenorhabditis elegans. Arch Biochem Biophys. 2016;589:27–37. doi: 10.1016/j.abb.2015.06.003. PubMed DOI

Gupta S, Knight AG, Gupta S, Keller JN, Bruce-Keller AJ. Saturated long-chain fatty acids activate inflammatory signaling in astrocytes. J Neurochem. 2012;120(6):1060–1071. doi: 10.1111/j.1471-4159.2012.07660.x. PubMed DOI PMC

Joshi-Barve S, Barve SS, Amancherla K, Gobejishvili L, Hill D, Cave M, Hote P, McClain CJ. Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes. Hepatology. 2007;46(3):823–830. doi: 10.1002/hep.21752. PubMed DOI

Schwenk RW, Holloway GP, Luiken JJ, Bonen A, Glatz JF. Fatty acid transport across the cell membrane: regulation by fatty acid transporters. Prostaglandins Leukot Essent Fatty Acids. 2010;82(4–6):149–154. doi: 10.1016/j.plefa.2010.02.029. PubMed DOI

Houthuijzen JM. For better or worse: FFAR1 and FFAR4 signaling in cancer and diabetes. Mol Pharmacol. 2016;90(6):738–743. doi: 10.1124/mol.116.105932. PubMed DOI

Wang X, He S, Gu Y, Wang Q, Chu X, Jin M, Xu L, Wu Q, Zhou Q, Wang B, Zhang Y, Wang H, Zheng L. Fatty acid receptor GPR120 promotes breast cancer chemoresistance by upregulating ABC transporters expression and fatty acid synthesis. EBioMedicine. 2019 doi: 10.1016/j.ebiom.2018.12.037. PubMed DOI PMC

Hardy S, St-Onge GG, Joly E, Langelier Y, Prentki M. Oleate promotes the proliferation of breast cancer cells via the G protein-coupled receptor GPR40. J Biol Chem. 2005;280(14):13285–13291. doi: 10.1074/jbc.M410922200. PubMed DOI

Hopkins MM, Zhang Z, Liu Z, Meier KE. Eicosopentaneoic acid and other free fatty acid receptor agonists inhibit lysophosphatidic acid- and epidermal growth factor-induced proliferation of human breast cancer cells. J Clin Med. 2016;5(2):E16. doi: 10.3390/jcm5020016. PubMed DOI PMC

Brookes PS. Mitochondrial H(+) leak and ROS generation: an odd couple. Free Radic Biol Med. 2005;38(1):12–23. doi: 10.1016/j.freeradbiomed.2004.10.016. PubMed DOI

Gutknecht J. Proton conductance caused by long-chain fatty acids in phospholipid bilayer membranes. J Membr Biol. 1988;106(1):83–93. doi: 10.1007/BF01871769. PubMed DOI

Schonfeld P, Schild L, Kunz W. Long-chain fatty acids act as protonophoric uncouplers of oxidative phosphorylation in rat liver mitochondria. Biochim Biophys Acta. 1989;977(3):266–272. doi: 10.1016/S0005-2728(89)80080-5. PubMed DOI

DeBerardinis RJ, Chandel NS. Fundamentals of cancer metabolism. Sci Adv. 2016;2(5):e1600200. doi: 10.1126/sciadv.1600200. PubMed DOI PMC

Patra KC, Hay N. The pentose phosphate pathway and cancer. Trends Biochem Sci. 2014;39(8):347–354. doi: 10.1016/j.tibs.2014.06.005. PubMed DOI PMC

Benito A, Polat IH, Noe V, Ciudad CJ, Marin S, Cascante M. Glucose-6-phosphate dehydrogenase and transketolase modulate breast cancer cell metabolic reprogramming and correlate with poor patient outcome. Oncotarget. 2017;8(63):106693–106706. doi: 10.18632/oncotarget.21601. PubMed DOI PMC

Lodish HF (1999) Molecular cell biology. W.H. Freeman, New York; Macmillan, Basingstoke

Hou NS, Gutschmidt A, Choi DY, Pather K, Shi X, Watts JL, Hoppe T, Taubert S. Activation of the endoplasmic reticulum unfolded protein response by lipid disequilibrium without disturbed proteostasis in vivo. Proc Natl Acad Sci USA. 2014;111(22):E2271–E2280. doi: 10.1073/pnas.1318262111. PubMed DOI PMC

Volmer R, Ron D. Lipid-dependent regulation of the unfolded protein response. Curr Opin Cell Biol. 2015;33:67–73. doi: 10.1016/j.ceb.2014.12.002. PubMed DOI PMC

Wek RC. Role of eIF2alpha kinases in translational control and adaptation to cellular stress. Cold Spring Harb Perspect Biol. 2018 doi: 10.1101/cshperspect.a032870. PubMed DOI PMC

Li Y, Guo Y, Tang J, Jiang J, Chen Z. New insights into the roles of CHOP-induced apoptosis in ER stress. Acta Biochim Biophys Sin (Shanghai) 2014;46(8):629–640. doi: 10.1093/abbs/gmu048. PubMed DOI

B’Chir W, Chaveroux C, Carraro V, Averous J, Maurin AC, Jousse C, Muranishi Y, Parry L, Fafournoux P, Bruhat A. Dual role for CHOP in the crosstalk between autophagy and apoptosis to determine cell fate in response to amino acid deprivation. Cell Signal. 2014;26(7):1385–1391. doi: 10.1016/j.cellsig.2014.03.009. PubMed DOI

B’Chir W, Maurin AC, Carraro V, Averous J, Jousse C, Muranishi Y, Parry L, Stepien G, Fafournoux P, Bruhat A. The eIF2alpha/ATF4 pathway is essential for stress-induced autophagy gene expression. Nucleic Acids Res. 2013;41(16):7683–7699. doi: 10.1093/nar/gkt563. PubMed DOI PMC

Levy JMM, Towers CG, Thorburn A. Targeting autophagy in cancer. Nat Rev Cancer. 2017;17(9):528–542. doi: 10.1038/nrc.2017.53. PubMed DOI PMC

Jaishy B, Abel ED. Lipids, lysosomes, and autophagy. J Lipid Res. 2016;57(9):1619–1635. doi: 10.1194/jlr.R067520. PubMed DOI PMC

Chikka MR, McCabe DD, Tyra HM, Rutkowski DT. C/EBP homologous protein (CHOP) contributes to suppression of metabolic genes during endoplasmic reticulum stress in the liver. J Biol Chem. 2013;288(6):4405–4415. doi: 10.1074/jbc.M112.432344. PubMed DOI PMC

Anelli T, Sannino S, Sitia R. Proteostasis and “redoxtasis” in the secretory pathway: tales of tails from ERp44 and immunoglobulins. Free Radic Biol Med. 2015;83:323–330. doi: 10.1016/j.freeradbiomed.2015.02.020. PubMed DOI

Anelli T, Alessio M, Mezghrani A, Simmen T, Talamo F, Bachi A, Sitia R. ERp44, a novel endoplasmic reticulum folding assistant of the thioredoxin family. EMBO J. 2002;21(4):835–844. doi: 10.1093/emboj/21.4.835. PubMed DOI PMC

Anelli T, Ceppi S, Bergamelli L, Cortini M, Masciarelli S, Valetti C, Sitia R. Sequential steps and checkpoints in the early exocytic compartment during secretory IgM biogenesis. EMBO J. 2007;26(19):4177–4188. doi: 10.1038/sj.emboj.7601844. PubMed DOI PMC

Cortini M, Sitia R. From antibodies to adiponectin: role of ERp44 in sizing and timing protein secretion. Diabetes Obes Metab. 2010;12(Suppl 2):39–47. doi: 10.1111/j.1463-1326.2010.01272.x. PubMed DOI

Hampe L, Radjainia M, Xu C, Harris PW, Bashiri G, Goldstone DC, Brimble MA, Wang Y, Mitra AK. Regulation and quality control of adiponectin assembly by endoplasmic reticulum chaperone ERp44. J Biol Chem. 2015;290(29):18111–18123. doi: 10.1074/jbc.M115.663088. PubMed DOI PMC

Chang Y, Wu Y, Liu W, Ji G. Knockdown of ERp44 leads to apoptosis via activation of ER stress in HeLa cells. Biochem Biophys Res Commun. 2015;463(4):606–611. doi: 10.1016/j.bbrc.2015.05.106. PubMed DOI

Huang X, Jin M, Chen YX, Wang J, Zhai K, Chang Y, Yuan Q, Yao KT, Ji G. ERP44 inhibits human lung cancer cell migration mainly via IP3R2. Aging (Albany NY) 2016;8(6):1276–1286. doi: 10.18632/aging.100984. PubMed DOI PMC